GH1 and growth: For patients diagnosed with disorders of growth requiring growth hormone therapy, large-scale data acquisition using a growth hormone delivery device with a connected monitoring platform (easypodTM), which automatically transmits adherence data via an online portal (easypodTM connect), can be used to predict an individual’s response to therapy relative to a population undergoing the same treatment, by integrating methodologies such as machine learning.